Karen Langhauser

The Constant Flow of Innovation
If history tells us anything, it’s this: in drug delivery, progress doesn’t come in bursts. It flows — steady, adaptable and always moving forward. read more
Making 2026 Pop
Much like the winemakers who learned to harness pressure rather than fear it, OSD manufacturers are leveraging advances in manufacturing processes, formulation science, excipients and packaging technologies. read more
Uncorking 2026: Industry leaders raise a glass to the future of OSD
As the industry looks toward 2026, oral solid dosage forms remain firmly at the center of pharmaceutical and nutraceutical innovation — but the forces shaping the market are becoming more complex and interconnected. read more
Chasing the North American Dream
Just as traveling salesmen once had to balance opportunity, risk and proximity to their customers, today’s pharmaceutical suppliers face similar pressures as they pursue the dream of the world’s largest pharma market. read more
North American Ambitions
Driven by persistent supply chain disruptions, shifting trade dynamics, evolving customer expectations and the accelerating growth of the nutraceutical sector, the pharma ecosystem is rewiring where — and how — it operates. read more
Coloring the Truth
While colors are up for interpretation, science generally is not. Health misinformation has always existed, but took centerstage during the pandemic when social media quickly became a powerful tool for disseminating false ... read more
Crossing the Red Line
The first federal ban on a synthetic color due to the outdated Delaney Clause has inked a line in the sand — and crossing it could push the industry past the threshold of science-driven formulation into an era ruled by consumer ... read more
What’s Next for Tableting?
Speed-to-market, efficiency, flexibility, quality. These aren’t just buzzwords — they’re critical goals every pharma manufacturer must achieve to bring new therapies to patients. The challenge lies in how to reach them. read more
Oral Solid Dose Mid-Year Regulatory Approval Update
As we edge past the midpoint of 2025, the U.S. oral solid dose sector has already put up some regulatory wins. Here’s a closer look at this year's OSD approvals. read more
The Hero Behind the Taste Mask
One could say that pharmaceutical excipients are the mild-mannered Clark Kents of drug formulation. Often described as ‘inactive’ ingredients, it’s easy to see how their role in the final drug product could be underestimated. read more
Capsules: Sealing the Future
Throughout history, humans have sought to ‘encapsulate’ time, preserving pieces of the present for the future. But when it comes to drug capsules, innovation has been anything but time-locked. read more
2025 Oral Solid Dose Regulatory Update
The industry’s most established and most favored dosage forms are coming off a strong 2024. How will 2025 compare? Here’s a closer look at the OSD approvals already making waves — and the decisions still on the horizon. read more
2025 Predictions: Industry Leaders Weigh in on the Future of Oral Solid Dose
New year, new advancements for the industry’s oldest and most beloved dosage form? It’s likely, according to experts. Here’s a look at what industry leaders in pharmaceuticals and nutraceuticals are predicting for the coming year. read more
What’s in the Cards for 2025?
Whether you’re reading tarot cards or gathering insights from industry, the future is always a mix of uncertainty and possibility. As we lay out the deck for 2025, I’m eager to see how the cards fall. read more
Give the Patient What She Wants
Today’s pharma manufacturers know that medication non-adherence is a critical barrier to effective treatment. Not only does this lead to poor health outcomes, but it’s also bad for business. read more
Patient-Centricity Stays in Style: Prioritizing Patient Preferences Proves More Than Just a Passing Trend at CPHI Milan
The CPHI show floor was buzzing with business dealings, but at the same time, the industry’s ability to trendset was on full display. read more